Zobrazeno 1 - 10 of 1 945 pro vyhledávání: '"Naicker, N"'
1
Akademický článek
Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb
Autor: Naicker N, Rodel H, Perumal R, Ganga Y, Bernstein M, Benede N, Abdool Karim S, Padayacthi N, Sigal A, Naidoo K
Publikováno v: Infection and Drug Resistance, Vol Volume 16, Pp 3629-3638 (2023)
Nikita Naicker,1 Hylton Rodel,2 Rubeshan Perumal,1 Yashica Ganga,2 Mallory Bernstein,2 Ntombi Benede,2 Salim Abdool Karim,1,3 Nesri Padayacthi,1,3 Alex Sigal,2,4,5 Kogieleum Naidoo1,3 1Centre for the AIDS Programme of Research in South Africa (CAPRIS
Externí odkaz: https://doaj.org/article/4770ee5401d54f8ab174780bc46926ae
Zobrazit plný text záznamu
2
Akademický článek
A scoping review of occupational biological exposures among horse grooms: a neglected group of workers in a thriving horse-racing industry.
Autor: Duba, T., Naicker, N., Singh, T.
Publikováno v: Occupational Health Southern Africa; 2024, Vol. 30 Issue 3, p125-132, 8p
Zobrazit plný text záznamu
3
Akademický článek
High burden of human papillomavirus and premalignant cervical lesions among women starting HIV treatment in KwaZulu-Natal, South Africa.
Autor: Naicker N; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa Nivashnee.Naicker@caprisa.org., Osman F; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa., Naidoo K; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa., Bodley N; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa., Mbambo N; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa., Madlala S; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa., Mhlongo T; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa., Mbatha N; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa., Maphumulo A; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa., Munatsi P; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa., Radebe P; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa., Liebenberg L; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa., Dorward J; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa.; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Drain PK; Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, Washington, USA.; Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.; Department of Medicine, School of Medicine, University of Washington, Seattle, Washington, USA., Garrett N; University of KwaZulu-Natal, Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa.; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Publikováno v: Sexually transmitted infections [Sex Transm Infect] 2024 Nov 18. Date of Electronic Publication: 2024 Nov 18.
Zobrazit plný text záznamu
4
Akademický článek
Preventing occupational injuries in the informal construction industry: a study protocol for the development of a safety education intervention for bricklayers and carpenters in Osun State, Nigeria.
Autor: Ojo TO; Department of Community Health, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.; Division of Occupational Health, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Onayade AA; Department of Community Health, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria., Naicker N; Division of Occupational Health, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Epidemiology and Surveillance, National Institute for Occupational Health, National Health Laboratory Services, Johannesburg, South Africa.
Publikováno v: Frontiers in public health [Front Public Health] 2024 Oct 09; Vol. 12, pp. 1464797. Date of Electronic Publication: 2024 Oct 09 (Print Publication: 2024).
Zobrazit plný text záznamu
5
Akademický článek
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial.
Autor: Dzienis M; Cancer Department, Gold Coast University Hospital, Southport, QLD, Australia., Cundom J; Department of Oncology, IDIM Instituto de Diagnóstico e Investigaciones Metabólicas, Buenos Aires, Argentina., Fuentes CS; Department of Oncology, Fundación Respirar, Buenos Aires, Argentina., Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada., Nordlinger M; Department of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson-Abington Hospital, Philadelphia, PA., Pastor AV; Department of Oncology, Hospital Provincial del Centenario, Rosario, Argentina., Alesi E; Department of Hematology/Oncology and Palliative Medicine, VCU Massey Cancer Center, Richmond, VA., Neki A; Department of Hematology/Oncology, UC Davis Medical Center, Sacramento, CA., Fung AS; Department of Oncology, Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, ON, Canada., Figueiredo Lima IP; Department of Oncology, Centro Regional Integrado de Oncologia, Fortaleza, Brazil., Oppelt P; Department of Oncology, Washington University School of Medicine, St Louis, MO., da Cunha Junior GF; Department of Oncology, CETUS Oncologia, Belo Horizonte, Brazil., Burtness B; Yale University School of Medicine and Yale Cancer Center, New Haven, CT., Franke FA; Department of Oncology, Oncosite Centro de Pesquisa Clínica em Oncologia, Ijuí, Brazil., Tseng JE; Department of Hematology and Oncology, Orlando Health Cancer Institute, Orlando, FL., Joshi A; Department of Medical Oncology, The Townsville University Hospital, Douglas, QLD, Australia., McCarthy J; Dr. H. Bliss Murphy Cancer Centre, St John's, NL, Canada., Swaby R; Merck & Co, Inc, Rahway, NJ., Sidi Y; Merck & Co, Inc, Rahway, NJ., Gumuscu B; Merck & Co, Inc, Rahway, NJ., Naicker N; Oncology European Clinical Development, MSD (UK) Limited, London, United Kingdom., de Castro G Jr; Clinical Oncology, Instituto do Câncer do Estado de São Paulo-ICESP, São Paulo, Brazil.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 01; Vol. 42 (25), pp. 2989-2999. Date of Electronic Publication: 2024 Jul 22.
Zobrazit plný text záznamu
6
Akademický článek
Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702.
Autor: Chihana R; Johns Hopkins Research Project, P.O Box 1131, Blantyre, Malawi. Electronic address: rkawalazira@jhp.mw., Jin Kee J; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA., Moodie Z; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA., Huang Y; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA., Janes H; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA., Dadabhai S; Johns Hopkins Research Project, P.O Box 1131, Blantyre, Malawi., Roxby AC; University of Washington, P.O Box 355852, WA 98195-5852, USA; Fred Hutchinson Cancer Center, P.O Box 19024, WA 98109-1024, Seattle, USA., Allen M; National Institutes of Health, 9000, Rockville Pike, Bethesda, USA., Kassim S; The Desmond Tutu HIV Centre, P.O Box 13801, Mowbray 7705, Cape Town, South Africa., Naicker V; South Africa Medical Research Council, P.O Box 19070, Cape Town, South Africa., Innes C; Aurum Institute, The Ridge, 29 Queens Road, Johannesburg, South Africa., Naicker N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Private Bag X7, Durban, South Africa., Dubula T; Walter Sisulu University, P. O Box 142, Eastern Cape, South Africa., Grunenberg N; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA., Malahleha M; Setshaba Research Centre, P.O Box 468, Pretoria, South Africa; Synergy Biomed Research Institute, 280 Oxford Street, East London 5201, South Africa., Kublin JG; Fred Hutchinson Cancer Center, P.O Box 19024, Seattle, WA 98109-1024, USA., Bekker LG; The Desmond Tutu HIV Centre, P.O Box 13801, Mowbray 7705, Cape Town, South Africa., Gray G; Perinatal HIV Research Unit, P.O Box 114, University of the Witwatersrand, South Africa., Kumwenda J; Johns Hopkins Research Project, P.O Box 1131, Blantyre, Malawi., Laher F; Perinatal HIV Research Unit, P.O Box 114, University of the Witwatersrand, South Africa.
Publikováno v: Vaccine [Vaccine] 2024 Aug 13; Vol. 42 (20), pp. 125991. Date of Electronic Publication: 2024 May 21.
Zobrazit plný text záznamu
7
Akademický článek
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
Autor: Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa., Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Dintwe OB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa., Omar FL; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa., Kee JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Naicker N; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa; and Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa., Jani I; Instituto Nacional de Saude, Maputo, Mozambique., Mgodi NM; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Hunidzarira P; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Sebe M; Aurum Institute, Tembisa, Gauteng, South Africa., Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Polakowski L; DAIDS, NIAID, NIH, Bethesda, Maryland, United States of America., Ramirez S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Nebergall M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Takuva S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Sikhosana L; Hutchinson Centre Research Institute of South Africa, Johannesburg, South Africa., Heptinstall J; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Seaton KE; Department of Surgery, Duke University, Durham, North Carolina, United States of America., De Rosa S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Diazgranados CA; Formerly Sanofi-Pasteur, Swiftwater, Pennsylvania, Pennsylvania, United States of America., Koutsoukos M; GSK, Wavre, Belgium., Van Der Meeren O; Previously GSK, Rixensart, Belgium., Barnett SW; Bill & Melinda Gates Foundation, Seattle, Washington, United States of America., Kanesa-Thasan N; Formerly GSK, Rockville, Maryland, United States of America., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Tomaras GD; Department of Surgery, Duke University, Durham, North Carolina, United States of America., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Mngadi K; Aurum Institute, Tembisa, Gauteng, South Africa., Goepfert P; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Publikováno v: PLoS medicine [PLoS Med] 2024 Mar 19; Vol. 21 (3), pp. e1004360. Date of Electronic Publication: 2024 Mar 19 (Print Publication: 2024).
Zobrazit plný text záznamu
8
Akademický článek
Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa.
Autor: Asare K; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; Health Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban, South Africa., Ngcapu S; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; Department of Medical Microbiology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa., Osman F; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa., Mindel A; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa., Naicker N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa., Khanyile M; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa., Karim SSA; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; Department of Epidemiology, Columbia University, New York, NY, USA., Tomita A; Centre for Rural Health, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa., Garrett N; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Publikováno v: International journal of STD & AIDS [Int J STD AIDS] 2024 Jan; Vol. 35 (1), pp. 58-66. Date of Electronic Publication: 2023 Sep 26.
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje